CRMD · CorMedix Inc.
$7.78
-0.64 (-7.60%)
At close · Jul 20
Market Cap
$610.36M
Shares
78.45M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-02 | 2026-06-29 | |
| 8-K | 2026-07-01 | 2026-06-25 | |
| 8-K | 2026-06-24 | 2026-06-23 | |
| 8-K | 2026-06-08 | — | |
| 8-K | 2026-05-14 | — | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| DEF 14A | 2026-04-29 | 2026-06-23 | |
| 8-K | 2026-04-27 | — | |
| 8-K | 2026-03-06 | — | |
| 8-K | 2026-03-05 | — | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-01-08 | 2026-01-05 | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| DEF 14A | 2025-10-24 | 2025-11-10 | |
| 8-K | 2025-10-20 | — | |
| 8-K/A | 2025-09-30 | 2025-08-29 | |
| 8-K | 2025-09-02 | 2025-08-28 | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | 2025-08-06 | |
| 8-K | 2025-06-30 | 2025-06-26 | |
| 8-K | 2025-06-25 | 2025-06-24 | |
| 8-K | 2025-06-23 | — | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-28 | 2025-06-24 | |
| 8-K | 2025-04-22 | 2025-04-17 | |
| 8-K | 2025-04-08 | — | |
| 10-K | 2025-03-25 | 2024-12-31 | |
| 8-K | 2025-03-25 | — | |
| 8-K | 2025-01-07 | — | |
| 8-K | 2024-11-25 | 2024-11-21 | |
| 8-K | 2024-10-30 | — | |
| 10-Q | 2024-10-30 | 2024-09-30 | |
| DEF 14A | 2024-10-08 | 2024-11-21 | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-14 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| 8-K | 2024-03-12 | — | |
| 10-K | 2024-03-12 | 2023-12-31 | |
| 8-K | 2024-01-30 | — | |
| 8-K | 2023-12-15 | 2023-12-12 | |
| 8-K | 2023-11-16 | 2023-11-15 | |
| 8-K | 2023-11-14 | — | |
| 10-Q | 2023-11-14 | 2023-09-30 | |
| 8-K | 2023-10-30 | 2023-10-26 | |
| DEF 14A | 2023-09-13 | 2023-10-26 | |
| 8-K | 2023-08-17 | 2023-08-14 |
Showing 1–50 of 122 filings
Key facts
CIK
1410098
CUSIP
21900C308
13F (30d)
14 filings
14 filers
Visit website
Investor relations